• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

First-Time Generics - September 2003

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
1 OFLOXACIN TABLETS 200 MG, 300 MG, AND 400 MG TEVA PHARMACEUTICALS USA FLOXIN TABLETS 9/2/2003
2 AMIODARONE HYDROCHLORIDE INJECTION 50 MG/ML; PACKAGED IN 150 MG/3 ML, 450 MG/9 ML, AND 900 MG/18 ML SINGLE-USE VIALS SICOR PHARMACEUTICALS, INC. CORDARONE I.V. INJECTION 9/5/2003
3 GLIPIZIDE EXTENDED-RELEASE TABLETS 5 MG WATSON LABORATORIES, INC. GLUCOTROL XK EXTENDED-RELEASE TABLETS 9/8/2003
4 MIDODRINE HYDROCHLORIDE TABLETS 2.5 MG, 5 MG, AND 10 MG MYLAN PHARMACEUTICALS, INC. PROAMATINE TABLETS 9/10/2003
5 PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS, USP 100 MG/500 MG AAI PHARMA DARVOCET-N 100 TABLETS 9/10/2003
6 DOXYCYCLINE CAPSULES, USP 75 MG (ADDITIONAL STRENGTH) RANBAXY LABORATORIES LIMITED MONODOX CAPSULES 9/10/2003
7 CEPHALEXIN TABLETS FOR ORAL SUSPENSION 125 MG AND 250 MG RANBAXY LABORATORIES LIMITED KEFLEX FOR ORAL SUSPENSION 9/11/2003
8 GABAPENTIN CAPSULES 100 MG, 300 MG, AND 400 MG PUREPAC PHARMACEUTICAL CO. NEOURONTIN CAPSULES 9/12/2003
9 HYDROCODONE BITARTRATE AND ACETAMINOPHEN ORAL SOLUTION 7.5 MG/325 MG PER 15 ML MIKART INC. LORTAB ELIXIR 9/25/2003
-
-